Related Experiment Video
Updated: Jul 17, 2025

Acupoint Catgut Embedding Therapy in Traditional Chinese Medicine for Managing Allergic Rhinitis
Published on: December 20, 2024
Cost-effectiveness Analysis of Inferior Turbinate Reduction and Immunotherapy in Allergic Rhinitis
Michael Yong1, Kaishan Aravinthan2, Keshinisuthan Kirubalingam3
1Department of Otolaryngology - Head & Neck Surgery, Stanford University School of Medicine, Stanford, California, U.S.A.
For allergic rhinitis with nasal obstruction, inferior turbinate reduction (ITR) before subcutaneous allergen immunotherapy (SCIT) is the most cost-effective strategy. This approach offers better value compared to other treatments for persistent symptoms.
Area of Science:
- Otolaryngology
- Allergy & Immunology
- Health Economics
Background:
- Allergic rhinitis (AR) frequently causes nasal obstruction due to atopic inferior turbinate hypertrophy (ITH).
- Current guidelines recommend subcutaneous allergen immunotherapy (SCIT) for pharmacologic treatment failures.
- The cost-effectiveness of inferior turbinate reduction (ITR) relative to other treatments remains unclear.
Purpose of the Study:
- To compare the cost-effectiveness of different treatment strategies for AR with nasal obstruction.
- To evaluate treatment sequences involving pharmacotherapy, allergy testing, SCIT, and ITR.
Main Methods:
- A 5-year cost-effectiveness analysis was performed.
- Four treatment combinations were compared: pharmacotherapy alone, SCIT, SCIT then ITR for non-responders, and ITR then SCIT for non-responders.
- Incremental cost-effectiveness ratios (ICERs) were calculated.
Main Results:
- Prioritizing ITR before SCIT emerged as the most cost-effective strategy for patients failing initial pharmacotherapy.
- Probabilistic sensitivity analysis confirmed this finding in 95.4% of scenarios.
- ITR demonstrated cost-effectiveness even when combined with septoplasty.
Conclusions:
- Inferior turbinate reduction (ITR) is a cost-effective treatment for AR patients with nasal obstruction due to ITH.
- ITR should be considered before pursuing immunotherapy for persistent symptoms.
- This strategy offers a valuable alternative to current treatment paradigms.
Related Concept Videos
Drugs Used in Lower Respiratory Disorders: Overview
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Drugs Used in Upper Respiratory Disorders: Overview
Antihistamines (e.g., Benadryl) block histamines from binding. Histamines are chemicals released during an allergic reaction in the body. As a...
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Chronic Pharyngitis
Etiology
It often arises from persistent viral or bacterial infections affecting sinuses and tonsils.
Additional contributing factors include inadequate dental hygiene, mouth breathing, recurring tonsillitis, allergic rhinitis, laryngopharyngeal reflux, and exposure to smoke, chemicals, and other environmental pollutants. Allergic reactions to pollen, mold, and pet dander, chronic cough, excessive voice usage,...
Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...

